DNA Vaccines for Anthrax: Targeting Afferent Immunity
DNA Vaccines for Anthrax: Targeting Afferent Immunity
批准号:
6646327
负责人:
ANDREW H SEGAL
金额:
$14.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-15 至 2005-02-14
中文摘要
描述(由申请人提供):B。炭疽是国家生物防御的主要关注的病原体。DNA疫苗在这方面具有许多潜在的优势。然而,它们通常仅引起适度的免疫应答。我们将生产炭疽的候选DNA疫苗,其中包含一种专有技术,该技术针对免疫系统的传入分支,显着放大免疫反应。该技术还可以加速响应。我们将在非感染性小鼠模型中测试我们的疫苗。
英文摘要
DESCRIPTION (provided by the applicant): B. anthracis is a pathogen of major concern for national biodefense. DNA vaccines have a number of potential advantages in this context. However, they often elicit only modest immune responses. We will generate candidate DNA vaccines for anthrax that incorporate a proprietary technology which targets the afferent limb of the immune system, markedly amplifying the immune response. The technology may also accelerate the response. We will test our vaccines in non-infectious mouse models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HA Based Opsonokines: A Novel Approach to Tumor Vaccines
-
批准号:7098878
-
项目类别:
-
资助金额:$41.12万
-
财政年份:2004
-
负责人:ANDREW H SEGAL
-
依托单位:
HA Based Opsonokines: A Novel Approach to Tumor Vaccines
-
批准号:6997970
-
项目类别:
-
资助金额:$43.49万
-
财政年份:2004
-
负责人:ANDREW H SEGAL
-
依托单位:
HA Based Opsonokines:A Novel Approach to Tumor Vaccines
-
批准号:6742125
-
项目类别:
-
资助金额:$22.32万
-
财政年份:2004
-
负责人:ANDREW H SEGAL
-
依托单位:
ENGINEERED OPSONINS FOR WHOLE CELL TUMOR VACCINES
-
批准号:6143080
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2000
-
负责人:ANDREW H SEGAL
-
依托单位:
WHOLE CELL TUMOR VACCINES BASED ON GPI LINKED MOLECULE
-
批准号:6017968
-
项目类别:
-
资助金额:$10.52万
-
财政年份:1999
-
负责人:ANDREW H SEGAL
-
依托单位:
CHIMERIC CELL-SURFACE CYTOKINE FOR TUMOR VACCINES
-
批准号:2715050
-
项目类别:
-
资助金额:$9.89万
-
财政年份:1998
-
负责人:ANDREW H SEGAL
-
依托单位:
DEVELOPMENT OF TUMOR VACCINES USING GPI LINKED MOLECULES
-
批准号:6021665
-
项目类别:
-
资助金额:$1.62万
-
财政年份:1997
-
负责人:ANDREW H SEGAL
-
依托单位:
DEVELOPMENT OF TUMOR VACCINES USING GPI-LINKED MOLECULES
-
批准号:2422939
-
项目类别:
-
资助金额:$8.45万
-
财政年份:1997
-
负责人:ANDREW H SEGAL
-
依托单位:
海外基金